{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T17:01:28Z","timestamp":1768582888162,"version":"3.49.0"},"reference-count":26,"publisher":"Hindawi Limited","issue":"3","license":[{"start":{"date-parts":[[2016,4,15]],"date-time":"2016-04-15T00:00:00Z","timestamp":1460678400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2016,4,15]],"date-time":"2016-04-15T00:00:00Z","timestamp":1460678400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"name":"Fuji Yakuhin Co., Ltd."},{"name":"Sanwa Kagaku Kenkyusho Co., Ltd."}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Pharm Ther"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1111\/jcpt.12392","type":"journal-article","created":{"date-parts":[[2016,4,15]],"date-time":"2016-04-15T11:29:05Z","timestamp":1460719745000},"page":"298-305","source":"Crossref","is-referenced-by-count":42,"title":["Clinical efficacy and safety of topiroxostat in Japanese male hyperuricemic patients with or without gout: an exploratory, phase 2a, multicentre, randomized, double\u2010blind, placebo\u2010controlled study"],"prefix":"10.1155","volume":"41","author":[{"given":"T.","family":"Hosoya","sequence":"first","affiliation":[{"name":"Department of Pathophysiology and Therapy in Chronic Kidney Disease Jikei University School of Medicine Tokyo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Sasaki","sequence":"additional","affiliation":[{"name":"Medical R&D Division Fuji Yakuhin Co., Ltd. Saitama Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Hashimoto","sequence":"additional","affiliation":[{"name":"Drug Development Center Sanwa Kagaku Kenkyusho Co., Ltd. Aichi Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Sakamoto","sequence":"additional","affiliation":[{"name":"Drug Development Center Sanwa Kagaku Kenkyusho Co., Ltd. Aichi Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Ohashi","sequence":"additional","affiliation":[{"name":"Medical R&D Division Fuji Yakuhin Co., Ltd. Saitama Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"98","published-online":{"date-parts":[[2016,4,15]]},"reference":[{"key":"e_1_2_7_2_1","first-page":"577","article-title":"Treatment of chronic gout. Can we determine when urate stores are depleted enough to prevent attacks of gout?","volume":"28","author":"Li\u2010Yu J","year":"2001","journal-title":"J Rheumatol"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.20405"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(67)90004-6"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(87)90441-4"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2004.00484.x"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2005.10.006"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.01580210"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-200018080-00021"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.0000221716.55088.d4"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.585"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1177\/106002809302700317"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(84)90743-5"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa050373"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.110.174540"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2009.08.091"},{"key":"e_1_2_7_17_1","first-page":"639","article-title":"Pharmacokinetics and pharmacodynamics study of topiroxostat by oral administration in subjects with renal impairment","volume":"43","author":"Nakazawa T","year":"2015","journal-title":"Jpn Pharmacol Ther"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1097\/00045391-200501000-00005"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.106.011692"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10157-014-0935-8"},{"key":"e_1_2_7_21_1","volume-title":"Guideline for the management of hyperuricemia and gout 1st edition: The classification of hyperuricemia (in Japanese)","author":"The Guideline Committee of Japanese Society of Gout, Nucleic Acid Metabolism","year":"2002"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4615-5381-6_3"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2008.12.034"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1097\/RHU.0b013e31821d36cc"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.89.14.6309"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2015.05.017"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10157-014-1032-8"}],"container-title":["Journal of Clinical Pharmacy and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjcpt.12392","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjcpt.12392","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jcpt.12392","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jcpt.12392","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jcpt.12392","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T18:01:24Z","timestamp":1671818484000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jcpt.12392"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,15]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["10.1111\/jcpt.12392"],"URL":"https:\/\/doi.org\/10.1111\/jcpt.12392","archive":["Portico"],"relation":{},"ISSN":["0269-4727","1365-2710"],"issn-type":[{"value":"0269-4727","type":"print"},{"value":"1365-2710","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,15]]}}}